Mimosa caesalpiniifolia
Mimosa caesalpiniifolia · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Mimosa caesalpiniifolia is a botanical species recognized for its diverse range of pharmacological activities, including antidepressant, antiproliferative, and genotoxic properties. Scientific investigations have focused on the plant's leaves and stems to uncover its therapeutic potential. These studies primarily utilize preparations such as dry extracts and ethyl acetate fractions to isolate bioactive compounds. The chemical profile of the plant is rich in essential constituents, including catechins, flavonoids, glycosides, and tannins. Through these specific chemical interactions, the species shows significant promise in addressing complex conditions like depression.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Stem
Classification
Common Names
Mimosa caesalpiniifolia is a versatile plant recognized by a diverse array of regional and international names. In many Brazilian contexts, it is affectionately or commonly referred to as Sabiá or Sansão-do-campo. Depending on the specific local tradition, you may also encounter it known as Cebiá or Unha-de-gato. Moving beyond South America, the species is identified in Poland as czułek brezylkolistny. These various monikers highlight the widespread cultural and botanical significance of this unique species.
Sources: Catalogue of Life (COL)
Taxonomy
Mimosa caesalpiniifolia belongs to the vast kingdom Plantae, representing a diverse group of multicellular organisms. Within this kingdom, the plant is classified under the class Equisetopsida. It further falls into the order Fabales, which helps define its biological placement. As a member of the family Fabaceae, it shares characteristics with many other well-known legumes. Finally, this specific species is categorized under the genus Mimosa, highlighting its unique botanical identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Mimosa |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Mimosa caesalpiniifolia exhibits a wide geographic distribution that spans across multiple continents. In Africa, the species is specifically found within the West Tropical region, including the Ivory Coast. Its presence is also heavily concentrated in Southern America, where it thrives throughout various parts of Brazil. The plant is widely established across the Brazilian landscape, ranging from the Northeast to the Southeast. Furthermore, its reach extends into both the North and South regions of the country, demonstrating remarkable adaptability.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Mimosa caesalpiniifolia is a self-supporting plant that takes the form of a sturdy tree. Depending on its environmental conditions, it can reach a maximum height of 6.5 meters. In some ideal growing locations, the species may even extend upward to reach 8 meters. This versatile growth habit makes it a distinctive feature in various landscapes.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Mimosa caesalpiniifolia is a native species of the Brazilian Caatinga that possesses diverse pharmacological properties of interest for phytotherapy. Research indicates that the plant has been studied for its potential antidepressant activity, although specific behavioral tests in rats have yielded complex results. Additionally, extracts from the stem bark have demonstrated significant antiproliferative effects against various human cancer cell lines. Studies also reveal that the plant can exhibit genotoxic action, specifically through the induction of chromosomal bridges and cell cycle arrest. These findings highlight the complex biological potential of the species and underscore the need for further investigation into its medicinal applications.
Compounds
Mimosa caesalpiniifolia is a native species of the Brazilian caatinga that possesses a diverse chemical profile. Scientific analysis of its leaves has confirmed the presence of various bioactive compounds, including flavonoids and glycosides. Furthermore, the plant contains significant amounts of tannins and specific phenolic structures. Detailed characterization via mass spectrometry also identified the presence of catechin and procyanidin B2 within the extract. These chemical findings contribute to a deeper understanding of the plant's potential medicinal properties.
Conditions
Mimosa caesalpiniifolia has been investigated for its potential to treat anti-inflammatory and antidepressant conditions. Research into the stem bark's dichloromethane fraction further demonstrates its antiproliferative capabilities. The plant also shows significant cytotoxic activity specifically against various cancer cell lines. Additionally, its bioactive compounds have been observed to induce cell cycle arrest and chromosomal bridges. These diverse pharmacological properties highlight the plant's complex therapeutic potential.
Preparations
Mimosa caesalpiniifolia is prepared as a dry extract using an extraction method involving simple percolation of the dried leaves. This plant is also prepared as an ethyl acetate fraction, which is obtained through a liquid-liquid partition process. During the preparation of the ethyl acetate fraction, part of the extractive solution is concentrated in a rotary evaporator and dried using a spray technique. The yield for the dry extract was measured at 33.33%, while the ethyl acetate fraction showed a lower mass yield of 19.67%. These two specific preparations were utilized in the study to evaluate the chemical profile and pharmacological activity of the species.
Parts used
Mimosa caesalpiniifolia is a native species from the Brazilian Caatinga that offers significant biomedical potential through its various plant parts. Research into the dry leaves of this species has focused on extracting bioactive compounds like phenolic acids and flavonoids to evaluate anti-inflammatory properties. Simultaneously, studies have investigated the stem bark to determine its cytotoxic and chemopreventive capabilities. Specifically, dichloromethane fractions derived from the stem have shown promising antiproliferative effects against various cancer cell lines. Together, these findings regarding the leaves and stem highlight the plant's importance as a source for future phytotherapy development.